期刊文献+

β淀粉样蛋白_(1-42)寡聚体和人重组α-突触核蛋白对原代培养神经元突触的影响 被引量:4

Effect of β-amyloid_(1-42) and Recombinant Human α-synuclein on Synapses of Primary Cultured Cortical and Hippocampal Neurons
原文传递
导出
摘要 目的探讨α-突触核蛋白(α-Syn)和β淀粉样蛋白(Aβ1-42)寡聚体对小鼠原代皮质、海马神经细胞突触功能和活性的影响。方法分别采用二甲基亚砜、Aβ42-1寡聚体、α-Syn、Aβ1-42寡聚体、α-Syn+Aβ42-1寡聚体、α-Syn+Aβ1-42寡聚体干预小鼠原代皮质和海马神经元,按不同干预方法分为6组。干预24 h后用免疫荧光、FM1-43染色法检测神经元的突触数量及活性,同时用Western blot法检测半胱氨酸伸展蛋白α(CSPα)表达。结果与其余5组比较,α-Syn+Aβ1-42寡聚体组可使突触相关CSPα表达明显下降(P<0.01)、与突触数目相关的突触蛋白Ⅰ明显降低(P<0.01),同时突触活性也明显下降(P<0.01)。结论α-Syn和Aβ1-42寡聚体可协同作用于神经元,减少CSPα表达,降低细胞突触数目及其功能。 Aim To explore the effect ofα-synuclein (α-syn) and β-amyloid1-42 (Aβ1-42) on the synapses of primary cultured cortical and hippocampal neurons.Methods Primary cultured neurons were divided into 6 groups,each group was treated by DMSO,Aβ42-1,α-syn,Aβ1-42,α-syn+Aβ42-1 and α-syn+Aβ1-42,respectively.After 24 hours incubation,the numbers and the activity of synapses were detected by the double immunofluorescence dying and FM 1-43 dying,meanwhile the expression of cysteine string proteinα (CSPα) were analyzed by Western blot.Results Compared with 5 other groups,α-syn+Aβ1-42 group could significantly decrease the expression of CSPα (P〈0.01),and synapse-associated synapsin Ⅰ could significantly decrease (P〈0.01),as well as the synaptic activity(P〈0.01).Conclusion α-syn together with Aβ1-42 could result in synergistic effect,which would decrease the expression of CSPα and then interact with synapses.The process finally reduced the function and activity of primary cultured cortical and hippocampal neurons.
出处 《中国临床神经科学》 2014年第1期13-19,共7页 Chinese Journal of Clinical Neurosciences
关键词 海马 神经元 突触功能障碍 Α-突触核蛋白 β淀粉样蛋白1-42 β淀粉样蛋白42-1 半胱氨酸伸展蛋白α hippocamp neuron synapse dysfunction α-synuclein β-amyloid1-42 β-amyloid42-1 cysteine-string protein α
作者简介 王艺璇,女(1991-),神经内科硕士研究生,主要从事帕金森病、痴呆的基础与临床研究. [通讯作者]丁正同,E-mail:zheding@htomail.com
  • 相关文献

参考文献19

  • 1Lim Y, Kehm VM, Lee EB, et al. o-Syn suppression reverses synaptic and memory defects in a mouse model of dementia with Lewy bodies [J]. J Neurosci,2011,31:10076-10087.
  • 2Cheng F, Vivacqua G, Yu S. The role of o-synuclein in neurotransmission and synaptic plasticity[J]. J ChemNeuroanat, 2011,42:242-248.
  • 3Kraybill ML, Larson EB, Tsuang DW, et al. Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both[J]. Neurology,2005,64:2069-2073.
  • 4Clinton LK, Blurton-Jones M, Myczek K, et al. Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline[J]. JNeurosci,2010,30: 7281-72895.
  • 5Evans NA, Facci L, Owen DE, et al. Abeta(1-42) reduces synapse number andinhibits neurite outgrowth in primary cortical and hippocampal neurons: a quantitative analysis [J]. J Neurosci Methods, 2008,175:96-103.
  • 6Sharma M, Burr6 J, Bronk P, et al. CSPct knockout causes neurodegeneration by impairing SNAP-25 function [J]. EMBO J, 2012,31:829-841.
  • 7Fernandez-Chacon R, Wolfel M, Nishimune H, et al. The synaptic vesicle protein CSP alpha prevents presynaptic degeneration [J]. Neuron,2004,42:237-251.
  • 8喻哲明,丁正同,任惠民,邬剑军,王坚,陈嬿.β淀粉样蛋白_(1-42)促进α-突触核蛋白在Ser129位点磷酸化和聚集[J].中国临床神经科学,2012,20(3):241-246. 被引量:4
  • 9Calkins MJ, Reddy PH. Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons [J]. BiochimBiophy Acta,2011,1812:507-513.
  • 10Bate C, Gentleman S, Williams A. synuclein induced synapse damage is enhanced by amyloid-l.42 [J]. Mol Neurodegener,2010, 5:55-55.

二级参考文献2

共引文献3

同被引文献124

  • 1Bekris LM, Mata IF, Zabetian CP. The genetics of Parkinson disease[J]. J Geriatr Psychiatry Neurol,2010, 23:228-242.
  • 2Dusa A, Kaylor J, Edridge S, et al. Characterization of oligomers during alpha-synuclein aggregation using intrinsic tryptophan fluorescence[J]. Biochemistry,2006,45:2752-2760.
  • 3Giasson BI, Forman MS, Higuchi M, et al. Initiation and synergistic fibrillization oftau and alpha-synuclein[J]. Science,2003,300:636-640.
  • 4Hong DP, Fink AL, Uversky VN. Smoking and Parkinson's disease: does nicotine affect alpha-synuclein fibrillation? [J]. Biochim Biophys Acta,2009,1794:282-290.
  • 5Kingsbury AE, Bandopadhyay R, Silveira-Moriyama L, et al. Brain stem pathology in Parkinson's disease: an evaluation of the Braak staging model[J]. Mov Disord,2010,25:2508-2515.
  • 6Uversky VN, Eliezer D. Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein[J]. Curr Protein Pept Sci,2009,10:483-499.
  • 7Li J, Uversky VN, Fink AL. Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein[J]. Biochemistry,2001, 40:11604-11613.
  • 8Goole J, Vanderbist F, Amighi K. Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms[J]. Int J Pharm,2007,334:35-41.
  • 9Devarakonda B, Hill RA, de Villiers MM. The effect of PAMAM dendrimer generation size and surface functional group on the aqueous solubility of nifedipine[J]. Int J Pharm,2004,284:133-140.
  • 10Milowska K, Malachowska M, Gabryelak T. PAMAM G4 dendrimers affect the aggregation of alpha-synuclein[J]. Int J Biol Macromol,2011,48:742-746.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部